MXPA06000760A - Composicion farmaceutica estable de carisoprodol y meloxicam. - Google Patents

Composicion farmaceutica estable de carisoprodol y meloxicam.

Info

Publication number
MXPA06000760A
MXPA06000760A MXPA06000760A MXPA06000760A MXPA06000760A MX PA06000760 A MXPA06000760 A MX PA06000760A MX PA06000760 A MXPA06000760 A MX PA06000760A MX PA06000760 A MXPA06000760 A MX PA06000760A MX PA06000760 A MXPA06000760 A MX PA06000760A
Authority
MX
Mexico
Prior art keywords
carisoprodol
meloxicam
pharmaceutical composition
composition containing
stable pharmaceutical
Prior art date
Application number
MXPA06000760A
Other languages
English (en)
Inventor
Regalado Antonio Santiago
Leon Sixto Serafin Espinoza
Original Assignee
Silanes Sa De Cv Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37897453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA06000760(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Silanes Sa De Cv Lab filed Critical Silanes Sa De Cv Lab
Priority to MXPA06000760A priority Critical patent/MXPA06000760A/es
Priority to ARP070100231A priority patent/AR059081A1/es
Priority to CO07005276A priority patent/CO5940095A1/es
Priority to US11/655,517 priority patent/US20070213324A1/en
Priority to PE2007000064A priority patent/PE20080106A1/es
Priority to GT200700005A priority patent/GT200700005A/es
Priority to EP07380012A priority patent/EP1810674A1/en
Publication of MXPA06000760A publication Critical patent/MXPA06000760A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invencion proporciona una composicion farmaceutica o formulacion, en forma de tabletas de estabilidad comprobada, asi como su proceso de obtencion, esta formulacion combina la accion terapeutica de meloxicam como antiinflamatorio y carisoprodol como analgesico y antiinflamatorio, que resulta efectos ventajoso al administrarse conjuntamente y que no se observan con la administracion de los componentes activos solos.
MXPA06000760A 2006-01-20 2006-01-20 Composicion farmaceutica estable de carisoprodol y meloxicam. MXPA06000760A (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
MXPA06000760A MXPA06000760A (es) 2006-01-20 2006-01-20 Composicion farmaceutica estable de carisoprodol y meloxicam.
ARP070100231A AR059081A1 (es) 2006-01-20 2007-01-18 Composicion farmaceutica estable de carisoprodol y meloxicam
CO07005276A CO5940095A1 (es) 2006-01-20 2007-01-19 Composicion farmaceutica estable de carisoprodol y meloxicam
US11/655,517 US20070213324A1 (en) 2006-01-20 2007-01-19 Stable pharmaceutical composition of carisoprodol and meloxicam
PE2007000064A PE20080106A1 (es) 2006-01-20 2007-01-19 Composicion farmaceutica estable de carisoprodol y meloxicam
GT200700005A GT200700005A (es) 2006-01-20 2007-01-19 Composicion farmaceutica estable de carisoprodol y meloxicam
EP07380012A EP1810674A1 (en) 2006-01-20 2007-01-19 Stable pharmaceutical composition containing carisoprodol and meloxicam

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA06000760A MXPA06000760A (es) 2006-01-20 2006-01-20 Composicion farmaceutica estable de carisoprodol y meloxicam.

Publications (1)

Publication Number Publication Date
MXPA06000760A true MXPA06000760A (es) 2007-07-19

Family

ID=37897453

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000760A MXPA06000760A (es) 2006-01-20 2006-01-20 Composicion farmaceutica estable de carisoprodol y meloxicam.

Country Status (7)

Country Link
US (1) US20070213324A1 (es)
EP (1) EP1810674A1 (es)
AR (1) AR059081A1 (es)
CO (1) CO5940095A1 (es)
GT (1) GT200700005A (es)
MX (1) MXPA06000760A (es)
PE (1) PE20080106A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1103205A2 (pt) * 2011-06-03 2014-02-25 Eurofarma Lab Ltda Composição farmacêutica oral e uso da composição farmacêutica oral
MX2018013458A (es) * 2018-11-05 2019-07-25 Federico Amezcua Amezcua Composicion farmaceutica que comprende la combinacion de un inhibidor selectivo de la ciclooxigenasa 2 y un carbamato derivado de la guaifenesina para el tratamiento del dolor, inflamacion y contractura muscular.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780463A (en) * 1984-12-26 1988-10-25 Analgesic Associates Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
AU3990895A (en) * 1995-12-05 1997-06-27 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
US20040204413A1 (en) 2001-01-26 2004-10-14 Joaquina Faour Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant
GB0224198D0 (en) * 2002-10-17 2002-11-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
PE20080106A1 (es) 2008-04-27
GT200700005A (es) 2007-08-28
CO5940095A1 (es) 2008-07-31
US20070213324A1 (en) 2007-09-13
AR059081A1 (es) 2008-03-12
EP1810674A1 (en) 2007-07-25

Similar Documents

Publication Publication Date Title
WO2009091576A3 (en) Parenteral formulations of dopamine agonists
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
MX2009005727A (es) Nanoparticulas de entidad anfifilica.
MX2009000812A (es) Soluciones de metotrexato concentradas.
PT2222669E (pt) Derivados de oxadiazole ativos em esfingosina-1-fosfato (s1p)
MX2009013835A (es) Forma de dosis estabilizada de picoplatino.
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
AU2010212580A8 (en) Stable pharmaceutical composition for atherosclerosis
NZ595467A (en) Sublingual pharmaceutical composition comprising a neutral oil
TN2012000371A1 (en) Pyrazole compounds as crth2 antagonists
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
MX2009007784A (es) Composiciones de tiacumicinas estables.
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
ZA200807027B (en) Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
MX2012007225A (es) Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
MXPA06000760A (es) Composicion farmaceutica estable de carisoprodol y meloxicam.
MX2017013633A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas.
UY30126A1 (es) Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
MA31227B1 (fr) Composition pharmaceutique renfermant du phloroglucinol et du paracetamol.
WO2008041116A3 (en) Formulations of active principles incorporated in slns suitable for transdermal administration
EA201290378A1 (ru) Композиции, содержащие нестероидные противовоспалительные лекарственные средства
BR112012020415A2 (pt) composição farmacêutica para a prevenção ou tratamento da osteoartrite
MX2017013643A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz.

Legal Events

Date Code Title Description
FG Grant or registration